US FDA approves Trogarzo, a new HIV drug „made-in-China“ (Taiwan)

Trogarzo™ (ibalizumab-uiyk) injection was developed by Taiwan’s Zhongyu New Drugs and is marketed in the US by Taiwan’s TaiMed Biologics. As a virus entry inhibitor,” ibalizumab binds to CD4, the major HIV receptor on the surface of T cells, to prevent these...